|
|
 |
| Frank Worden, David Fink and Susan Urba are leading the first phase 1 clinical trial to test gene therapy for the relief of chronic pain. |
|
|
 |
| U-M neurologist David Fink, left, and U-M oncologists Frank Worden and Susan Urba discuss the phase 1 clinical trial they are leading to test gene therapy for the relief of chronic pain. |
|
|